R Felldin Lcsw-r Clinical Support | |
205 Algerine St Afton NY 13730-2203 | |
(607) 639-1215 | |
Not Available |
Full Name | R Felldin Lcsw-r Clinical Support |
---|---|
Speciality | Clinic/center - Adolescent And Children Mental Health |
Location | 205 Algerine St, Afton, New York |
Authorized Official Name and Position | Robin Felldin (OWNER) |
Authorized Official Contact | 6076391215 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
R Felldin Lcsw-r Clinical Support 205 Algerine St Afton NY 13730-2203 Ph: (607) 639-1215 | R Felldin Lcsw-r Clinical Support 205 Algerine St Afton NY 13730-2203 Ph: (607) 639-1215 |
NPI Number | 1518677178 |
---|---|
Provider Enumeration Date | 12/05/2022 |
Last Update Date | 12/05/2022 |
Certification Date | 12/05/2022 |
Identifier | Type | State | Issuer |
---|---|---|---|
1518677178 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QM0855X | Clinic/center - Adolescent And Children Mental Health | (* (Not Available)) | Primary |
News Archive
Researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate Research Center at Oregon Health & Science University have received a $3.5 million grant from the National Institutes of Health to develop new methods for vaccinating humans against human immunodeficiency virus (HIV), the virus that causes AIDS.
Electroconvulsive therapy (ECT) is considered the most effective treatment option for patients with severe depression who cannot find symptom relief through antidepressant medications or psychotherapy. In a new study, researchers at Butler Hospital and Bradley Hospital in Rhode Island found a sharp decline in the availability and use of ECT in general hospitals across the U.S.
Following a number of recent outbreaks of E. coli, or Escherichia coli, bacteria at grocers and restaurants across the country, Building Health Check, LLC, has released an Indoor Air Quality (IAQ) Screening Kit for the E. coli bacteria.
The Board of Directors of Patterson Companies, Inc., today declared the quarterly cash dividend of $0.16 per share. The dividend will be payable on January 24, 2014, to shareholders of record on January 10, 2014.
Hospitals in the U.S. continue to make progress in the fight against central line-associated bloodstream infections and some surgical site infections, according to a report issued today by the Centers for Disease Control and Prevention (CDC). Catheter-associated urinary tract infections remained unchanged between 2010 and 2011.
› Verified 7 days ago